跳至主要内容
临床试验/NCT06482840
NCT06482840进行中(未招募)不适用

Safety and Efficacy of EasyCool Catheter - Prospective Monocentric Study

MedFact Engineering GmbH1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2023年12月8日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
15
试验地点
1
主要终点
Removal of treated cardiac arrythmia

研究概览

简要总结

The goal of this observational study is to learn about risks and benefit of EasyCool Catheter for cardiovascular ablation in real-world patients suffering from cardiac arrythmias.

The main question[s] it aims to answer are:

  • will the cardiac arrythmia be removed and remain absent oc recurrent also 3 months after procedure
  • what are the adverse events at procedure, after 3 and 6 months

All participants will receive cardiac ablation with EasyCool catheter.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients requiring intracardial RF- Ablation with irrigated catheter

排除标准

  • Absence of patient´s consent;
  • Age <12 years;
  • Pregnancy or breast-feeding women;
  • Acute local infection;
  • Acute systemic infection;
  • Atrial thrombosis or myxoma - the transseptal approach is contraindicated in patients with left atrial thrombus;
  • Existence of active Implants (Pacemaker, Defibrillator etc.);
  • Hemodynamic instability;
  • Hypercoagulability;
  • Inadequate tissue damaged e.g. by radiation or suppuration;
  • Obstruction of the artery or vein selected for insertion;
  • Patients with artificial heart valve: the use of intracardial catheters is not advised;
  • Physiologic or anatomic abnormalities that could cause postoperative complications e.g. aneurysms in the application area, bleeding diathesis, decreased resistance to infections;
  • Previously diagnosed spasms of the coronary arteries;
  • Recurrent metastasizing cancer;
  • Severe concomitant illness for which an increase or surgery time is associated with a significant increased risk;
  • Thrombosis of the leg veins and the deep pelvic vein.

结局指标

主要结局

Removal of treated cardiac arrythmia

时间窗: 3 months after procedure

Removal of treated cardiac arrhythmia and absence of recurrence of the arrythmia

次要结局

  • Adverse Events(at procedure, after 3 and 6 months)

研究者

发起方
MedFact Engineering GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Safety and Efficacy of EasyCool Catheter | 临床试验